Emtricitabine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Emtricitabine
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Emtricitabine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 17 USDMF, 2 JDMF, 15 EU WC, 5 KDMF, 19 NDC API, 17 Listed Suppliers, $ API Reference Price

32 API Suppliers
17 USDMF
2 JDMF
15 EU WC
5 KDMF
19 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

163 FDF Dossiers, 53 FDA Orange Book, 32 Europe, 24 Canada, 41 South Africa, 13 Listed Dossiers

163 FDF Dossiers
53 FDA Orange Book
32 Europe
24 Canada
41 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
TABLET;ORAL - 120MG;EQ 15MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE
CAPSULE;ORAL - 200MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 8 DKSH, 6 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 32 Controlled & Modified Release, 23 Thickeners and Stabilizers, 22 Granulation, 21 Direct Compression, 19 Disintegrants & Superdisintegrants, 17 Solubilizers, 16 Topical, 15 Lubricants & Glidants, 12 Film Formers & Plasticizers, 11 Parenteral, 11 Taste Masking, 9 Co-Processed Excipients, 9 Empty Capsules, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 3 Rheology Modifiers

63 Fillers, Diluents & Binders
53 Coating Systems & Additives
32 Controlled & Modified Release
23 Thickeners and Stabilizers
22 Granulation
21 Direct Compression
19 Disintegrants & Superdisintegrants
17 Solubilizers
16 Topical
15 Lubricants & Glidants
12 Film Formers & Plasticizers
11 Parenteral
11 Taste Masking
9 Co-Processed Excipients
9 Empty Capsules
7 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
3 Surfactant & Foaming Agents
3 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 STOCK RECAP #PipelineProspector, 192 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
2 STOCK RECAP #PipelineProspector
192 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 29 Finished Drug Prices, 55 Annual Reports

5 US Medicaid Prescriptions
29 Finished Drug Prices
55 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

8 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

111 US Patents, 11 US Exclusivities, 2 Health Canada Patents

111 US Patents
11 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 4 Others

3 USP
4 Others

$ API Ref.Price (USD/KG) : 344 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Gilead Sciences Canada Inc.

02 1Blank

filter Patent Reset all filters

2 All

01 12009637

02 12075189

filter Product Reset all filters

2 All

01 1Emtricitabine

02 1Blank

filter Dosage Reset all filters

2 All

01 1Capsule

02 1Blank

filter Exp Date Reset all filters

2 All

01 12010-02-08

02 12011-01-31

Product Main Page

01

Gilead Sciences Canada Inc.

Emtricitabine

BioAsia

Not Confirmed

Gilead Sciences Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-01-31

Date Granted : 2004-11-30

Emtricitabine

Brand Name : EMTRIVA

Patent Number : 2075189

Filing Date : 1991-01-31

Strength per Unit : 200mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-01-31

Date Granted : 2004-11-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Emtricitabine

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-02-08

Date Granted :

Emtricitabine

Brand Name :

Patent Number : 2009637

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2010-02-08

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!